7. Dinapoli, R.P., et al., Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high- grade glioma. J Clin Oncol, 1993. 11(7): p. 1316 -1321. 8. Pickard, J.D., et al., Ste ps towards cost -benefit analysis of regional neurosurgical care. Br Med J, 1990. 301(6753): p. 629- 635. 9. Ekman, M. and M. Westphal, Cost of brain tumour in Europe. Eur J Neurol, 2005. 12: p. 45 -9. 10. Imperato, J.P., N.A. Paleologos, and N.A. Vick, Effec ts of treatment on long- term survivors with malignant astrocytomas. Ann Neurol, 1990. 28(6): p. 818 -822. 11. Hall, W.A. and O. Fodstad, Immunotoxins and central nervous system neoplasia. J Neurosurg, 1992. 76(1): p. 1-12. 12. Banchereau, J. and R.M. Steinm an, Dendritic cells and the control of immunity. Nature, 1998. 392 (6673): p. 245- 52. 13. Steinman, R.M., Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mount Sinai Journal of Medicine, 2001. 68(3): p. 106- 66. 14. Fujii, S., et al., Analysis of a chronic myelogenous leukemia patient vaccinated with leukemic dendritic cells following autologous peripheral blood stem cell transplantation. Japanese Journal of Cancer Research, 1999. 90(10): p. 1117 -29.